Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Target practice in severe asthma.

Stephanie A Christenson1

  • 1Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.

Science Translational Medicine
|March 31, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Summary of Research: Dupilumab for Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Pooled Analysis of Two Phase 3, Randomised, Double-Blind, Placebo-Controlled Trials.

Pulmonary therapy·2026
Same author

Disease modification and progression in pre-chronic obstructive pulmonary disease: an official American Thoracic Society workshop report.

Annals of the American Thoracic Society·2026
Same author

A Quantitative Lung Mucin Score to Identify Chronic Bronchitis.

NEJM evidence·2026
Same author

Hair follicle gene expression profiling in the SubPopulations and InteRmediate Outcome Measures in COPD Study (SPIROMICS).

BMC medical genomics·2025
Same author

Acute Respiratory Distress Syndrome Molecular Phenotypes Have Distinct Lower Respiratory Tract Transcriptomes.

American journal of respiratory and critical care medicine·2025
Same author

Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation.

Science translational medicine·2025
Same journal

Erratum for the Research Article "Guanosine diphosphate-mannose suppresses homologous recombination repair and potentiates antitumor immunity in triple-negative breast cancer".

Science translational medicine·2026
Same journal

CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

Science translational medicine·2026
Same journal

Bioresponsive microneedle stent provides anastomosis and postoperative adjuvant therapy in preclinical resectable intestinal diseases.

Science translational medicine·2026
Same journal

Alzheimer's disease proteome-wide association study implicates adaptive immunity and identifies risk genes LILRB1 and SIRPA.

Science translational medicine·2026
Same journal

KSHV-infected endothelial cells expand and up-regulate angiogenic pathways and CXCR4 in patient-derived Kaposi sarcoma models.

Science translational medicine·2026
Same journal

Hypoxia-driven T cell-macrophage-stromal cross-talk sustains fibrosis in preclinical models of cutaneous chronic graft-versus-host disease.

Science translational medicine·2026
See all related articles

The NLRP3 inflammasome pathway, involving caspase-1 and IL-1β, shows potential as a therapeutic target for severe steroid-resistant asthma. Targeting this axis could offer new treatment options for difficult-to-treat asthma cases.

Area of Science:

  • Immunology
  • Pulmonology
  • Inflammation Research

Background:

  • Severe asthma, particularly steroid-resistant forms, presents significant unmet clinical needs.
  • The inflammasome pathway, including NLRP3, caspase-1, and IL-1β, plays a critical role in inflammatory processes.
  • Dysregulation of these inflammatory mediators is implicated in severe airway diseases.

Purpose of the Study:

  • To investigate the role of the NLRP3 inflammasome/caspase-1/IL-1β axis in severe steroid-resistant asthma.
  • To evaluate the potential of targeting this axis as a therapeutic strategy.

Main Methods:

  • Analysis of inflammasome components (NLRP3, caspase-1, IL-1β) in patient samples.
  • Assessment of inflammasome activation in response to stimuli.

Related Experiment Videos

  • Evaluation of the effects of inhibiting the NLRP3 inflammasome pathway.

    • Main Results:

    • Evidence suggests significant activation of the NLRP3 inflammasome/caspase-1/IL-1β axis in severe steroid-resistant asthma.
    • Inhibition of this pathway demonstrated a reduction in inflammatory markers and asthma severity in preclinical models.

    Conclusions:

    • The NLRP3 inflammasome/caspase-1/IL-1β axis is a key player in severe steroid-resistant asthma pathogenesis.
    • Targeting this axis represents a promising therapeutic avenue for patients with severe, refractory asthma.